Category: Include on Menu
-
Gold rises back above $5,000 as Iran conflict and central bank meetings dominate market focus
Gold prices moved higher during Asian trading on Tuesday, climbing back above key levels as investors monitored developments in the U.S.-Israel conflict with Iran, fluctuations in oil prices and a series of central bank policy meetings scheduled for this week. The precious metal had briefly slipped below the $5,000-per-ounce mark in the previous session. However,…
-
Futures slip as oil rises, RBA hikes rates and Nvidia outlines massive AI sales outlook: Dow Jones, S&P, Nasdaq, Wall Street
U.S. stock futures pointed lower on Tuesday as investors weighed geopolitical tensions around Iran and disruptions to global energy supply. Oil prices climbed following fresh security incidents near the Strait of Hormuz, while gold edged higher ahead of a key Federal Reserve meeting later this week. Meanwhile, the Reserve Bank of Australia increased interest rates…
-
Why industrial gases are the gold of the digital age
Part 3 of a 3-part investor series In the first two installments of this series, we explored how U.S. Energy Corp. (NASDAQ:USEG) has evolved from a traditional E&P company into an emerging industrial gas and carbon management platform — and how its 2026 plan sets the foundation for multi‑stream, long‑duration value creation. Part 3 zooms out. Because…
-
Sharp Pullback By Oil Prices Sparks Rebound On Wall Street
After moving notably lower over the past few sessions, stocks showed a strong move back to the upside during trading on Monday. The major averages all moved notably higher, with the tech-heavy Nasdaq leading the way. The major averages ended the day off their highs of the session but still sharply higher. The Nasdaq surged…
-
CytomX highlights clinical progress for lead cancer drug in Q4 update
CytomX Therapeutics Inc. (NASDAQ:CTMX) used its fourth-quarter 2025 earnings call to highlight progress in the clinical development of its lead drug candidate, Varseta-M, while outlining its broader strategy for future growth. Although the company did not disclose detailed financial results during the call, investors reacted positively to the update, sending the stock sharply higher in…
-
Meiwu launches AI initiative to support functional skincare research
Meiwu Technology Company Limited (NASDAQ:WNW) said it is introducing a strategic initiative aimed at integrating artificial intelligence tools into its research processes to support the development of functional skincare products. The company said the program will focus on using AI-assisted data analysis to improve internal research coordination, evaluate product formulations and strengthen collaboration with external…
-
Telos posts strong fourth-quarter growth, raises 2026 revenue and EBITDA outlook
Telos Corporation (NASDAQ:TLS) reported strong revenue growth in the fourth quarter of 2025, supported by expanding demand for its security solutions, though the company remained in a GAAP loss position. Revenue for the quarter reached $46.8 million, representing a 77% increase year over year, driven largely by a 105% surge in the Security Solutions segment…
-
Marvell and Lumentum to showcase optical circuit switching for AI data centers at OFC 2026
Marvell Technology (NASDAQ:MRVL) and Lumentum Holdings (NASDAQ:LITE) said they will present a live demonstration of integrated optical networking technologies designed for next-generation artificial intelligence infrastructure at the OFC 2026 conference in Los Angeles. The demonstration will feature Marvell optical connectivity solutions working alongside Lumentum’s optical circuit switching (OCS) platform in a rack-level system. The joint…
-
PTC Sells IoT Businesses and Plans Large Share Buyback
PTC (NASDAQ:PTC) announced that on March 16, 2026 it finalized the previously disclosed sale of its Kepware industrial connectivity unit and ThingWorx IoT platform to an affiliate of TPG in a cash transaction valued at $523 million. The divestiture is intended to help the company concentrate more closely on its Intelligent Product Lifecycle strategy. After…
-
Acumen Secures Funding to Advance Enhanced Brain Delivery Program
Acumen Pharmaceuticals (NASDAQ:ABOS) announced that on March 13, 2026 it agreed to sell 10,833,331 common shares at a price of $3.30 each in a private placement with institutional accredited investors. The transaction is expected to generate gross proceeds of roughly $35.75 million, which the company plans to use to support development of its Enhanced Brain…